Showing results (121-130 of 389) with videos related to

Sort By:
Pageof 39
Japanese Journal of Clinical Oncology|March 16, 2016
Characteristics and overall survival of EGFR mutation-positive non-small cell lung cancer treated with EGFR tyrosine kinase inhibitors: a retrospective analysis for 1660 Japanese patientsAkira Inoue, Kazushi Yoshida, Satoshi Morita, et al.
Lung Cancer (Amsterdam, Netherlands)|March 3, 2018
Real world treatment and outcomes in EGFR mutation-positive non-small cell lung cancer: Long-term follow-up of a large patient cohortIsamu Okamoto, Satoshi Morita, Naoki Tashiro, et al.
Investigational New Drugs|December 1, 2014
Infected complex renal cysts during crizotinib therapy in a patient with non-small cell lung cancer positive for ALK rearrangementYasuto Yoneshima, Isamu Okamoto, Masako Arimura-Omori, et al.
Lung Cancer (Amsterdam, Netherlands)|November 8, 2017
CD44 variant-dependent regulation of redox balance in EGFR mutation-positive non-small cell lung cancer: A target for treatmentYuko Kawano, Eiji Iwama, Kenji Tsuchihashi, et al.
Journal for Immunotherapy of Cancer|January 11, 2025
Krebs von den Lungen-6 surveillance in immune checkpoint inhibitor-induced pneumonitisRyosuke Matsukane, Shoji Nakamura, Haruna Minami, et al.
Future Oncology (London, England)|January 11, 2020
Therapies after first-line afatinib in patients with <i>EGFR</i>m<sup>+</sup> NSCLC in Japan: retrospective analysis of LUX-Lung 3Hiroshige Yoshioka, Terufumi Kato, Isamu Okamoto, et al.
BMC Cancer|February 8, 2020
Differential significance of molecular subtypes which were classified into EGFR exon 19 deletion on the first line afatinib monotherapyNahomi Tokudome, Yasuhiro Koh, Hiroaki Akamatsu, et al.
Cancer Science|June 23, 2015
Afatinib versus cisplatin plus pemetrexed in Japanese patients with advanced non-small cell lung cancer harboring activating EGFR mutations: Subgroup analysis of LUX-Lung 3Terufumi Kato, Hiroshige Yoshioka, Isamu Okamoto, et al.
Cancer Science|January 25, 2018
Osimertinib in patients with epidermal growth factor receptor T790M advanced non-small cell lung cancer selected using cytology samplesKatsuyuki Kiura, Kiyotaka Yoh, Nobuyuki Katakami, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 30, 2018
Intrinsic and Extrinsic Regulation of PD-L2 Expression in Oncogene-Driven Non-Small Cell Lung CancerDaisuke Shibahara, Kentaro Tanaka, Eiji Iwama, et al.
Pageof 39